相关实验视频

Updated: Jul 8, 2025

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

40.4K

D-Dimer与淋巴细胞比率之间的关系和HBV相关的减补性肝硬化病的死亡率

YuanYuan Yu, XiaoTing Qi

    Clinical laboratory
    |December 12, 2023
    PubMed
    概括

    血D-二分体与淋巴细胞比率 (DLR) 可以预测B型肝炎病毒相关的失补偿性肝硬化 (HBV-DC) 患者的30天死亡率. 较高的DLR表明预后更差,为风险评估提供了有价值的非侵入性工具.

    更多相关视频

    Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection04:11

    Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

    Published on: December 15, 2023

    3.4K
    Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

    Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

    Published on: October 20, 2021

    3.0K

    相关概念视频

    Hazard Ratio01:12

    Hazard Ratio

    The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
    For example, in a clinical trial...
    130